The Korea Tuberculosis Association (Chairman Kyung Man-ho) signed a business agreement with Bandio Co., Ltd. on the 20th to establish a foundation for diagnosing tuberculosis and various respiratory infectious diseases at home and abroad.
Bandio Co., Ltd. is a company specializing in the development of experimental equipment and microbial culture medium. It provides technology for diagnosing respiratory infectious diseases, including tuberculosis.
The Tuberculosis Association expected that "the business agreement with Bandio Co., Ltd., which has GMP facilities, will greatly increase the efficiency of the development and production of standard badges needed to diagnose tuberculosis."
"The importance of rapid and accurate diagnosis of respiratory infectious diseases is being emphasized as we go through Corona19. We expect a breakthrough in technology in the field of diagnosing future respiratory infectious diseases, not just tuberculosis," said Kyung Man-ho, president of the Tuberculosis Association